SPIRE CORP
10QSB, EX-27, 2000-11-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: SPIRE CORP, 10QSB, 2000-11-14
Next: AMPAL AMERICAN ISRAEL CORP /NY/, 10-Q, 2000-11-14



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S UNAUDITED CONSOLIDATED BALANCE SHEETS AND STATEMENTS OF OPERATIONS ON
FORM 10-QSB FINANCIAL STATEMENTS FOR THE PERIOD ENDED SEPTEMBER 30, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FORM 10-QSB.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JUL-01-2000
<PERIOD-END>                                   SEP-30-2000
<CASH>                                           7,625,883
<SECURITIES>                                             0
<RECEIVABLES>                                    3,080,208
<ALLOWANCES>                                       108,000
<INVENTORY>                                      2,042,907
<CURRENT-ASSETS>                                13,081,588
<PP&E>                                          14,976,777
<DEPRECIATION>                                  12,815,637
<TOTAL-ASSETS>                                  15,360,937
<CURRENT-LIABILITIES>                            3,413,210
<BONDS>                                                  0
                                    0
                                              0
<COMMON>                                            38,794
<OTHER-SE>                                      11,908,933
<TOTAL-LIABILITY-AND-EQUITY>                    15,360,937
<SALES>                                          4,277,674
<TOTAL-REVENUES>                                10,516,977
<CGS>                                            3,156,462
<TOTAL-COSTS>                                   11,304,518
<OTHER-EXPENSES>                                         0
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                (787,541)
<INCOME-PRETAX>                                   (425,218)
<INCOME-TAX>                                      (298,619)
<INCOME-CONTINUING>                               (126,599)
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                      (126,599)
<EPS-BASIC>                                          (0.04)
<EPS-DILUTED>                                        (0.04)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission